Access and Barriers to Childhood Immunization Among Migrant Populations

  • Pier Luigi LopalcoEmail author
Part of the SpringerBriefs in Public Health book series (BRIEFSPUBLIC)


Vaccine preventable diseases are mostly under control in the EU, thanks to successful immunisation programmes. Nevertheless, immunisation gaps still exist among the European child population. Pockets of susceptible population may jeopardise priority public health programmes like the measles and rubella elimination programme and represent a threat for keeping the polio-free status. Children belonging to disadvantaged groups, including families with migrant background, are considered at higher risk for some vaccine preventable disease. The increased risk is mainly linked to difficult access to vaccination services and subsequent low vaccination coverage in local communities. Language barriers, lack of targeted communication strategies, the absence of diversity-oriented organisation behaviours, altogether contribute to create a hostile environment for improving the compliance of migrant families to childhood vaccination programmes.


Vaccine preventable diseases Childhood vaccination programmes Public health Vaccination coverage Barriers Diversity-oriented organisation Migrant families 


  1. APMNews. (2017). Agnès Buzyn veut mettre en place l'obligation vaccinale pédiatrique pour 11 valences (presse)., 16 June 2017. Accessed 09 Sept 2017.
  2. Beebeejaun, K., Degala, S., Balogun, K., et al. (2017). Outbreak of hepatitis A associated with men who have sex with men (MSM), England, July 2016 to January 2017. Euro Surveillance, 22(5).Google Scholar
  3. Borras, E., Dominguez, A., Batalla, J., et al. (2007). Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain). Vaccine, 25, 3240–3243.CrossRefGoogle Scholar
  4. Bottcher, S., Neubauer, K., Baillot, A., et al. (2015). Stool screening of Syrian refugees and asylum seekers in Germany, 2013/2014: Identification of Sabin like polioviruses. International Journal of Medical Microbiology, 305(7), 601–606.CrossRefGoogle Scholar
  5. Cai, W., Poethko-Muller, C., Hamouda, O., & Radun, D. (2011). Hepatitis B virus infections among children and adolescents in Germany: Migration background as a risk factor in a low seroprevalence population. The Pediatric Infectious Disease Journal, 30(1), 19–24.CrossRefGoogle Scholar
  6. Carrillo-Santisteve, P., Tavoschi, L., Severi, E., et al. (2017). Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: A systematic review. The Lancet Infectious Diseases. CrossRefGoogle Scholar
  7. Chiaradia, G., Gualano, M., Di Thiene, D., et al. (2011). Health status of immigrant children: An epidemiological survey among Italian paediatricians. Italian Journal of Public Health, 8, 268–274.Google Scholar
  8. Day, M. (2017). Doctor and MPs in Italy are assaulted after vaccination law is passed. BMJ, 358, j3721.CrossRefGoogle Scholar
  9. de la Fuente, I. G., Wagner, N., Siegrist, C.-A., & Posfay-Barbe, K. M. (2013). Tetanus immunity as a surrogate for past diphtheria-tetanus-pertussis immunization in migrant children. The Pediatric Infectious Disease Journal, 32(3), 274–277.PubMedGoogle Scholar
  10. European Centre for Disease Prevention and Control. (2016a). Epidemiological assessment of hepatitis B and C among migrants in the EU/EEA. Stockholm: ECDC. Accessed 28 Aug 2017.
  11. European Centre for Disease Prevention and Control. (2016b). Systematic review on hepatitis B and C prevalence in the EU/EEA. Stockholm: ECDC. Accessed 28 Aug 2017.
  12. European Centre for Disease Prevention and Control. (2016c). Annual epidemiological report 2016 – Invasive meningococcal disease. Stockholm: ECDC. Accessed 28 Aug 2017.
  13. European Centre for Disease Prevention and Control. (2016d). Annual epidemiological report 2016 – Tetanus. Stockholm: ECDC; 2016. Accessed 28 Aug 2017.
  14. European Centre for Disease Prevention and Control. (2017). Vaccine scheduler. Stockholm: ECDC. Accessed 09 Sept 2017.
  15. Freidl, G. S., Sonder, G. J., Bovee, L. P., et al. (2017). Hepatitis A outbreak among men who have sex with men (MSM) predominantly linked with the EuroPride, the Netherlands, July 2016 to February 2017. Euro Surveillance, 22(8).Google Scholar
  16. Giambi, C., Del Manso, M., Bella, A., et al. (2017). Rosolia congenita e in gravidanza News Accessed 28 Aug 2017.
  17. Grabmeier-Pfistershammer, K., Herkner, H., Touzeau-Roemer, V., et al. (2015). Low tetanus, diphtheria and acellular pertussis (Tdap) vaccination coverage among HIV infected individuals in Austria. Vaccine, 33(32), 3929–3932.CrossRefGoogle Scholar
  18. Hardelid, P., Cortina-Borja, M., Williams, D., Tookey, P. A., Peckham, C. S., Cubitt, W. D., & Dezateux, C. (2009). Rubella seroprevalence in pregnant women in North Thames: Estimates based on newborn screening samples. Journal of Medical Screening, 16(1), 1–6.CrossRefGoogle Scholar
  19. Haverkate, M., D’Ancona, F., Giambi, C., Johansen, K., et al. (2012). Mandatory and recommended vaccination in the EU, Iceland and Norway: Results of the VENICE 2010 survey on the ways of implementing national vaccination programmes. Euro Surveillance, 17(22), pii=20183.Google Scholar
  20. Hope, V. D., Eramova, I., Capurro, D., & Donoghoe, M. C. (2014). Prevalence and estimation of hepatitis B and C infections in the WHO European Region: A review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiology and Infection, 142(2), 270–286.CrossRefGoogle Scholar
  21. Kakoulidou, M., Forsgren, M., Lewensohn-Fuchs, I., & Johansen, K. (2010). Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes. Vaccine, 28(4), 1002–1007.CrossRefGoogle Scholar
  22. King, L. A., Lévy-Bruhl, D., O'Flanagan, D., et al. (2008). Introduction of Human Papillomavirus (HPV) vaccination into national immunisation schedules in Europe: Results of the Venice 2007 survey. Eurosurveillance, 13(33).Google Scholar
  23. Mikolajczyk, R. T., Akmatov, M. K., Stich, H., Kramer, A., & Kretzschmar, M. (2008). Association between acculturation and childhood vaccination coverage in migrant populations: A population based study from a rural region in Bavaria, Germany. International Journal of Public Health, 53(4), 180–187.CrossRefGoogle Scholar
  24. Mipatrini, D., Stefanelli, P., Severoni, S., & Rezza, G. (2017). Vaccinations in migrants and refugees: A challenge for European health systems. A systematic review of current scientific evidence. Pathogens and Global Health, 111(2), 59–68.CrossRefGoogle Scholar
  25. Mullaert, J., Abgrall, S., Lele, N., et al. (2015). Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study. Vaccine, 33(38), 4938–4944.CrossRefGoogle Scholar
  26. O’Connor, P., Jankovic, D., Muscat, M., et al. (2017). Measles and rubella elimination in the WHO Region for Europe: Progress and challenges. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 23(8), 504–510.CrossRefGoogle Scholar
  27. Oostvogel, P. M., van Wijngaarden, J. K., van der Avoort, H. G., et al. (1994). Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992–93. Lancet, 344(8923), 665–670.CrossRefGoogle Scholar
  28. Poethko-Muller, C., Ellert, U., Kuhnert, R., et al. (2009). Vaccination coverage against measles in German-born and foreign-born children and identification of unvaccinated subgroups in Germany. Vaccine, 27(19), 2563–2569.CrossRefGoogle Scholar
  29. Rapisarda, V., Bracci, M., Nunnari, G., et al. (2014). Tetanus immunity in construction workers in Italy. Occupational Medicine (Oxford, England), 64(3), 217–219.CrossRefGoogle Scholar
  30. Rosano, A., Dauvrin, M., Buttigieg, S. C., Ronda, E., Tafforeau, J., & Dias, S. (2017). Migrant’s access to preventive health services in five EU countries. BMC Health Services Research, 17(1), 588.CrossRefGoogle Scholar
  31. Sane, J., Sorvari, T., Widerstrom, M., et al. (2016). Respiratory diphtheria in an asylum seeker from Afghanistan arriving to Finland via Sweden, December 2015. Euro Surveillance, 21(2).Google Scholar
  32. Scavia, G., Alfonsi, V., Taffon, S., et al. (2017). A large prolonged outbreak of hepatitis A associated with consumption of frozen berries, Italy, 2013–14. Journal of Medical Microbiology, 66(3), 342–349.CrossRefGoogle Scholar
  33. Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G., & Ott, J. J. (2015). Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet (London, England), 386(10003), 1546–1555.CrossRefGoogle Scholar
  34. Shulman, L. M., Gavrilin, E., Jorba, J., et al. (2014). Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013. Euro Surveillance, 19(7), 20709.PubMedGoogle Scholar
  35. Steens, A., Mollema, L., Berbers, G. A. M., et al. (2010). High tetanus antitoxin antibody concentrations in the Netherlands: A seroepidemiological study. Vaccine, 28(49), 7803–7809.CrossRefGoogle Scholar
  36. Tabibi, R., Baccalini, R., Barassi, A., et al. (2013). Occupational exposure to zoonotic agents among agricultural workers in Lombardy Region, northern Italy. Annals of Agricultural and Environmental Medicine, 20(4), 676–681.PubMedGoogle Scholar
  37. Tafuri, S., Martinelli, D., Melpignano, L., et al. (2010). High level immunity against poliomyelitis in African and Asian refugees in southern Italy. Journal of Travel Medicine, 17(3), 203–205.CrossRefGoogle Scholar
  38. Tavoschi, L., Severi, E., Niskanen, T., et al. (2015). Food-borne diseases associated with frozen berries consumption: A historical perspective, European Union, 1983 to 2013. Euro Surveillance, 20(29), 21193.PubMedGoogle Scholar
  39. van Wijngaarden, J. K., & van Loon, A. M. (1993–1994). The polio epidemic in The Netherlands, 1992/1993. Public Health Reviews, 21(1–2), 107–116.PubMedGoogle Scholar
  40. Werber, D., Michaelis, K., Hausner, M., et al. (2017). Ongoing outbreaks of hepatitis A among men who have sex with men (MSM), Berlin, November 2016 to January 2017 – linked to other German cities and European countries. Euro Surveillance, 22(5).Google Scholar
  41. Whelan, J., Sonder, G., Heuker, J., & van den Hoek, A. (2012). Incidence of acute hepatitis B in different ethnic groups in a low-endemic country, 1992–2009: Increased risk in second generation migrants. Vaccine, 30(38), 5651–5655.CrossRefGoogle Scholar
  42. Whelan, J., Sonder, G., & van den Hoek, A. (2013). Declining incidence of hepatitis A in Amsterdam (The Netherlands), 1996–2011: Second generation migrants still an important risk group for virus importation. Vaccine, 31(14), 1806–1811.CrossRefGoogle Scholar
  43. WHO. (2016). Circulating vaccine-derived poliovirus outbreaks in 5 countries, 2014–2015. Releve Epidemiologique Hebdomadaire, 91(6), 71–72.Google Scholar
  44. WHO Country office Tajikistan, Regional Office for Europe, & European Centre for Disease Prevention and Control. (2010). Outbreak of poliomyelitis in Tajikistan in 2010: Risk for importation and impact on polio surveillance in Europe? Euro Surveillance, 15(17).Google Scholar
  45. Williams, G. A., Bacci, S., Shadwick, R., et al. (2016). Measles among migrants in the European Union and the European Economic Area. Scandinavian Journal of Public Health, 44(1), 6–13.CrossRefGoogle Scholar
  46. World Health Organisation. (2012). WHO position paper on hepatitis A vaccines – June 2012. Releve Epidemiologique Hebdomadaire, WHO Regional Office for Europe, Copenhagen, Denmark, 87(28/29), 261–276.Google Scholar
  47. World Health Organisation. (2014). Centralized information system for infectious diseases (CISID). WHO Regional Office for Europe, Copenhagen, Denmark, Accessed 09 Sept 2017.Google Scholar
  48. World Health Organization (WHO) Regional Office for Europe. (2012). Surveillance guidelines for measles, rubella and congenital rubella syndrome in the WHO European Region.Google Scholar
  49. World Health Organization (WHO) Regional Office for Europe. (2014). European Vaccine Action Plan 2015–2020.Google Scholar

Copyright information

© The Author(s), under exclusive licence to Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Università di PisaPisaItaly

Personalised recommendations